Financial statements Bioerg
Balance sheet data of BIOERG
|
Year
|
2020
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 4 869 679,09 | 9 189 377,11 | 18 221 283,49 |
| A. Fixed assets | 737 673,97 | 940 596,95 | 1 767 179,83 |
| B. Current assets | 4 132 005,12 | 8 248 780,16 | 16 454 103,66 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 4 869 679,09 | 9 189 377,11 | 18 221 283,49 |
| A. Equity | 1 021 169,05 | 2 512 734,18 | 4 314 238,95 |
| B. Liabilities and provisions for liabilities | 3 848 510,04 | 6 676 642,93 | 13 907 044,54 |
| I. Long-term liabilities | 0,00 | 29 461,90 | 14 931,52 |
| II. Short-term liabilities | 3 269 512,85 | 5 770 684,45 | 11 141 561,31 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.